Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research

Dartmouth-Hitchcock Medical Center29 enrolled

Overview

The purpose of this study is to collect a blood or bone marrow sample from patients with multiple myeloma and from volunteers without myeloma.

The blood and bone marrow samples will be used in the laboratory to perform focused studies on multiple myeloma.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Multiple Myeloma

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Participant population is multiple myeloma patients over the age of 18 who are undergoing a scheduled bone marrow collection and/or blood drawing procedure as part of their routine treatment or follow up, and healthy volunteers over the age of 18 who have agreed to have a bone marrow and/or blood harvest as part of a donation to a transplant recipient. Exclusion Criteria: * Patients, who in the opinion of their physician, would be adversely affected by removal of an extra15ml of blood and /or an extra 10ml of bone marrow.

Locations (1)

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States

Outcomes

Primary Outcomes

Cancer cell response to molecular testing of killing cell parts.

This myeloma specific killing may help identify mechanisms, in vitro, of killing myeloma cells for the future use in clinical trials.

Time frame: 2 Years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.